Literature DB >> 6317183

A recovered avian myelocytomatosis virus that induces lymphomas in chickens: pathogenic properties and their molecular basis.

P J Enrietto, L N Payne, M J Hayman.   

Abstract

The avian myelocytomatosis virus MC29 induces neoplastic diseases in chicken, including myelocytomas and tumors of kidney and liver, which are due to the action of the v-myc gene. However, MC29 has never been reported to cause lymphoid tumors, the disease associated with activation of the c-myc gene by the insertion of a lymphoid leukosis virus genome. We have analyzed a recovered MC29 virus, HBI, which has a myc gene containing c-myc sequences, acquired by recombination with the cellular gene, and some v-myc sequences. Inoculation of HBI into chickens resulted in lymphoid tumors independent of the bursa. Antigenically these tumors were made up of T and B cells. Molecular analysis showed HBI proviral DNA in 36 of 39 tumors analyzed, with no obvious alteration of c-myc, and the HBI gag-myc fusion protein, p 108, could be detected in tumor cells. These data are discussed in terms of the mechanism of target-cell specificity for transformation by the myc gene.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6317183     DOI: 10.1016/0092-8674(83)90170-8

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  27 in total

1.  Heart tumors specifically induced in young avian embryos by the v-myc oncogene.

Authors:  S Saule; J P Mérigaud; A E Al-Moustafa; F Ferré; P M Rong; P Amouyel; B Quatannens; D Stéhelin; F Dieterlen-Lièvre
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

2.  myc products induce the expression of catecholaminergic traits in quail neural crest-derived cells.

Authors:  M Fauquet; D Stehelin; S Saule
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

3.  Two additional protein-tyrosine kinases expressed in human lung: fourth member of the fibroblast growth factor receptor family and an intracellular protein-tyrosine kinase.

Authors:  U Holtrich; A Bräuninger; K Strebhardt; H Rübsamen-Waigmann
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

4.  myc and src oncogenes have complementary effects on cell proliferation and expression of specific extracellular matrix components in definitive chondroblasts.

Authors:  S Alema; F Tato; D Boettiger
Journal:  Mol Cell Biol       Date:  1985-03       Impact factor: 4.272

5.  Nucleotide sequence of HBI, a novel recombinant MC29 derivative with altered pathogenic properties.

Authors:  D R Smith; B Vennstrom; M J Hayman; P J Enrietto
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

6.  A retroviral myc gene induces preneoplastic transformation of lymphocytes in a bursal transplantation assay.

Authors:  P Neiman; C Wolf; P J Enrietto; G M Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

7.  Isolation of genomic DNA from the earthworm species Eisenia fetida.

Authors:  C el Adlouni; M J Mukhopadhyay; P Walsh; G G Poirier; D Nadeau
Journal:  Mol Cell Biochem       Date:  1995-01-12       Impact factor: 3.396

8.  Synergism of v-myc and v-Ha-ras in the in vitro neoplastic progression of murine lymphoid cells.

Authors:  R C Schwartz; L W Stanton; S C Riley; K B Marcu; O N Witte
Journal:  Mol Cell Biol       Date:  1986-09       Impact factor: 4.272

9.  Inhibition of HIV-1 replication by cyclopentenone prostaglandins in acutely infected human cells. Evidence for a transcriptional block.

Authors:  C Rozera; A Carattoli; A De Marco; C Amici; C Giorgi; M G Santoro
Journal:  J Clin Invest       Date:  1996-04-15       Impact factor: 14.808

10.  Induction and down-regulation of PLK, a human serine/threonine kinase expressed in proliferating cells and tumors.

Authors:  U Holtrich; G Wolf; A Bräuninger; T Karn; B Böhme; H Rübsamen-Waigmann; K Strebhardt
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.